Pancancer analysis suggested that PLAU and CTSK were differentially expressed in pancreatic cancer and other cancers such as kidney chromophobe, stomach adenocarcinoma, and v = ovarian serous cystadenocarcinoma (Figures 4(a) and 4(b)). Here, PLAU is linked to pancreatic neoplasm.